Mozhgan Derakhshan-sefidi

Dr. Mozhgan Derakhshan-sefidi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2025 in New Microbes and New Infections
Verified
Journal Article
Open access
SSSahel Safaei
Sahel Safaei
MDMozhgan Derakhshan-sefidi
Mozhgan Derakhshan-sefidi
AKAmirmohammad Karimi
Amirmohammad Karimi
Arboviruses constitute the largest known group of viruses and are responsible for various infections that impose significant socioeconomic burdens worldwide, particularly due to their link with insect-borne diseases. The increasing incidence of dengue fever in non-endemic regions underscores the urgent need for innovative strategies to combat this public health threat. Wolbachia, a bacterium, presents a promising biological control method against mosquito vectors, offering a novel approach to managing dengue fever. We systematically investigated biomedical databases (PubMed, Web of Science, Google Scholar, Science Direct, and Embase) using “AND” as a Boolean operator with keywords such as “dengue fever,” “dengue virus,” “risk factors,” “Wolbachia,” and “outbreak.” We prioritized articles that offered significant insights into the risk factors contributing to the outbreak of dengue fever and provided an overview of Wolbachia's characteristics and functions in disease management, considering studies published until December 25, 2024.

29 January 2025 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
MDMozhgan Derakhshan-sefidi
Mozhgan Derakhshan-sefidi
FEFereshteh Eidy
Fereshteh Eidy
SNSomayyeh Nadi-Ravandi
Somayyeh Nadi-Ravandi
SBSareh Bagheri-Josheghani
Sareh Bagheri-Josheghani
MMMaryam Mirfakhraei
Maryam Mirfakhraei
Bacterial gastroenteritis is a significant public health concern, capable of causing severe infections. Among the various pathogens involved, those belonging to the Enterobacteriaceae family are the most frequently isolated and associated with gastrointestinal disorders. This study aimed to investigate the prevalence of common diarrheagenic Enterobacteriaceae in Iran over the past two decades, from 2000 to 2023. A comprehensive systematic search was conducted across multiple databases, including EMBASE, HINARI, MEDLINE, PubMed, Google Scholar, and the Cochrane Library. The focus was on observational published studies reporting the prevalence of diarrheagenic Enterobacteriaceae in Iran during 2000 and 2023. The criteria did not restrict patient demographics such as age, gender, health conditions, or occupation. This meta-analysis employed a 95% confidence interval (CI) for analysis. Evidence of heterogeneity was determined using an I² value greater than 50%. To explore potential sources of heterogeneity, subgroup analysis and meta-regression analysis were performed. Statistical analyses were executed using R version 4.3.2 along with the meta package. A p-value less than 0.05 was considered statistically significant. Out of 3,701 papers reviewed, 56 studies met the inclusion criteria and were analyzed. The overall pooled prevalence of diarrheagenic Enterobacteriaceae species from 2000 to 2023 was 14.0% (95% CI: 0.11–0.17). Subgroup analysis revealed Shigella spp. had the highest prevalence at 18.0% (95% CI: 0.13–0.24; I²=99%), followed by diarrheagenic Escherichia coli at 11.0% (95% CI: 0.09–0.15; I²=97%), Salmonella spp. at 9.0% (95% CI: 0.05–0.17; I²=99%), and Yersinia spp. at 2.0% (95% CI: 0.00-0.10; I²=94%). Prevalence trends showed Shigella spp. increasing from 4% (95% CI: 0.03–0.08) in 2000–2004 to 36% (95% CI: 0.20–0.55) in 2021–2023. Diarrheagenic E. coli (DEC) showed no clear pattern, ranging from 5% (95% CI: 0.01–0.24) to 17% (95% CI: 0.07–0.36). Salmonella spp. exhibited more significant fluctuations, rising from 6% (95% CI) in both 2000–2004 and 2005–2008 periods to 20% (95% CI: 0.03–0.66) in 2009–2012 and 30% (95% CI: 0.11–0.60) in 2017–2020. Yersinia spp. was only determined in 2000–2004 with a pool prevalence of 12% (95% CI: 0.00-0.91). Sub-species analysis revealed Shigella sonnei was the most prevalent species among Shigella spp. in Iran, accounting for 42% of cases (95% CI: 0.33–0.52). Regarding DEC species, Enteroaggregative E. coli (EAEC) and Enterotpathogenic E. coli (EPEC) had the highest rate at 15% (95% CI). Furthermore, a pool prevalence of 2% (95% CI: 0.00-0.89) was reported for Yersinia enterocolitica among diarrheagenic Enterobacteriaceae in Iran. This meta-analysis provides valuable insights into the prevalence of diarrheagenic Enterobacteriaceae in Iran over the past two decades. The findings highlight the significant impact of these pathogens on public health, with Shigella spp. showing the highest prevalence and increasing trends. Further research should investigate the factors contributing to the prevalence of diarrheagenic Enterobacteriaceae, including genetic diversity of diarrheagenic Enterobacteriaceae isolates, molecular mechanisms underlying the virulence of these pathogens, or antibiotic resistance patterns.

24 December 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MDMozhgan Derakhshan-sefidi
Mozhgan Derakhshan-sefidi
BBBita Bakhshi
Bita Bakhshi
FHFarzaneh Hamidi
Farzaneh Hamidi
SSSahel Safaei
Sahel Safaei
SSSaeed Shams
Saeed Shams
SBSareh Bagheri-Josheghani
Sareh Bagheri-Josheghani
Campylobacteriosis is a major cause of gastroenteritis globally, but comprehensive data on its prevalence and antimicrobial resistance (AMR) patterns in Ir

30 October 2025 in Microbial Genomics
Verified
Journal Article
Open access
BBBita Bakhshi
Bita Bakhshi
ENElisabeth Njamkepo
Elisabeth Njamkepo
MDMozhgan Derakhshan-sefidi
Mozhgan Derakhshan-sefidi
MPMohammad R. Pourshafie
Mohammad R. Pourshafie
CJClaire Jenkins
Claire Jenkins
FWFrançois-Xavier Weill
François-Xavier Weill
Cholera epidemics due to Vibrio cholerae O1 El Tor have been occurring in Iran since 1965, but the incidence of this disease has declined significantly over time. We found that multiple sublineages of the seventh pandemic V. cholerae O1 El Tor lineage have caused cholera outbreaks in Iran, suggesting recurrent introductions of the disease from South Asia into Iran.